Manon Evain

机构：Université Paris-Saclay, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Paul-Brousse · ORCID：0000-0002-9409-2887

发表论文 18 篇 · 总被引 158 次 · h-index 5

代表论文

• Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab (2022 · Liver International · 被引 48)
• A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC (2022 · Liver International · 被引 38)
• Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab (2023 · Hepatology · 被引 31)
• Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab (2024 · Digestive and Liver Disease · 被引 21)
• Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival (2022 · Transplantation · 被引 14)
• Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study (2025 · Alimentary Pharmacology & Therapeutics · 被引 3)